NYSE:PFEPharmaceuticals
Pfizer (PFE) Valuation in Focus After EU Patent Lawsuit Threatens Paxlovid Revenue Streams
If you’ve been watching Pfizer (PFE) lately, the latest legal action from Enanta Pharmaceuticals may have caught your eye. Enanta has filed a patent infringement suit against Pfizer’s blockbuster COVID-19 antiviral, Paxlovid, across 18 EU countries. While this does not mean immediate disruption to Pfizer’s operations, the stakes in the European market and potential costs tied to a negative outcome are significant for investors, especially as the company faces ongoing revenue and patent...